Erweiterte Suche

Leslie L. Shoemaker ist Mitglied des Vorstands von Coffey Geotechnics Ltd. und Präsident bei Tetra Tech, Inc. Dr. Shoemaker erhielt einen Undergraduate-Abschluss vom Hamilton College (New York), einen Graduate-Abschluss von der Cornell University und einen Doktortitel von der University of Maryland.

Peter Shoemaker is currently the Chairman at Critical Alert Systems LLC, Director at ExtruMed, Inc., Managing Director at Wedbush Capital Partners, Director at Passport Foods (SVC) LLC, Director at Visual Communications Co. LLC, Partner at American Discovery Capital LLC, and Operating Advisor at Seminal Capital Holdings LLC.
He previously worked as a Director at Energy Solutions International, Inc., Managing Director at Alvin V.
Shoemaker Investments, Inc., and Director at ExtruMed LLC.
Mr. Shoemaker received his undergraduate degree from the University of Pennsylvania in 1986 and his MBA from the University of Southern California in 1994.

David Shoemaker's current job(s) include being the Chief Executive Officer & Director at Alereon, Inc. since 2013, and the Chief Executive Officer at The Canadian Olympic Committee since 2019.
Dr. Shoemaker's former job(s) include being the Chief Executive Officer at NBA Sports Culture Development (Beijing) Co., Ltd., the Engineering Director at RF Micro Devices, Inc., the Manager & Developer at Texas Instruments Incorporated, the Vice President-Engineering at TZero Technologies, Inc., the Manager & Developer at Engim, Inc., and the Chief Operating Officer & General Counsel at Wta Tour, Inc.Dr. Shoemaker's education history includes undergraduate, graduate, and doctorate degrees from Massachusetts Institute of Technology.

Lorie Shoemaker is a professional with a doctorate degree from the Medical University of South Carolina and a graduate degree from the University of Phoenix.
She is currently a member of The Elizabeth Hospice, Inc. and Sigma Theta Tau International Honor Society of Nursing, Inc. She has previously worked as a Professor at San Diego State University, Chief Nurse Executive Officer at Palomar Health, and Principal at California Hospital Association.
She was also a member of the American Organization of Nurse Executives.

Mary Teresa Shoemaker is an Independent Director at Traws Pharma, Inc. She previously served as the President, Chief Executive Officer & Director at Medexus Pharma, Inc. from 2018 to 2020.
Prior to that, she held the position of Senior Director-Commercial Operations at Pharmion Corp.
She also worked as the Vice President-Sales at InterMune, Inc. from 2009 to 2010 and as the President-United States Operations at Medexus Pharmaceuticals, Inc. Ms. Shoemaker holds a graduate degree from the University of Central Missouri and an undergraduate degree from Missouri State University.

Diane Shoemaker currently works as a Sales Manager at Fountainhead Development, Inc.